Coversyl Comp Novum

Coversyl Comp Novum 10 mg/2.5 mg is a combination medicine used to treat high blood pressure by helping to relax blood vessels and increase urine output.

Form
tabletti, kalvopäällysteinen
Strength
10 mg / 2.5 mg
Active Ingredient
Perindopril arginine
Manufacturer
Les Laboratoires Servier

How to Use

Dosage

One tablet once daily.

Method

Take the tablet in the morning before a meal with a glass of water.

Important

Do not take more than one tablet per day.

Possible Side Effects

COMMON
  • •Low potassium in the blood
  • •Skin reactions in people prone to allergies or asthma
  • •Headache
  • •Dizziness
  • •Vertigo
  • •Tingling sensation
  • •Vision disturbances
  • •Ringing in the ears (tinnitus)
  • •Cough
  • •Shortness of breath
  • •Digestive issues (nausea, vomiting, stomach pain, taste disturbance, indigestion, diarrhea, constipation)
  • •Allergic reactions (like rashes, itching)
  • •Muscle cramps
  • •Fatigue
RARE
  • •Mood changes
  • •Depression
  • •Sleep disturbances
  • •Hives (urticaria)
  • •Red spots on the skin (purpura)
  • •Blister clusters
  • •Kidney problems
  • •Impotence (inability to get or maintain an erection)
  • •Sweating
  • •Increased number of eosinophils (a type of white blood cell)
  • •Changes in lab values: high potassium in the blood (reverses after stopping treatment), low sodium in the blood (can lead to dehydration and low blood pressure)
  • •Drowsiness
  • •Fainting
  • •Palpitations (awareness of heartbeats)
  • •Fast heartbeat (tachycardia)
  • •Very low blood sugar (hypoglycemia) in diabetic patients
  • •Blood vessel inflammation (vasculitis)
  • •Dry mouth
  • •Photosensitivity reactions (skin sensitivity to sunlight)
  • •Joint pain (arthralgia)
  • •Muscle pain (myalgia)
  • •Chest pain
  • •Feeling unwell
  • •Swelling of the extremities
  • •Fever
  • •Increased blood urea levels
  • •Increased blood creatinine levels
  • •Falls
  • •Worsening of psoriasis
  • •Changes in lab values: low chloride, low magnesium, increased liver enzymes, high bilirubin in blood
  • •Reduced or no urine output; acute kidney failure
  • •Dark urine, nausea or vomiting, muscle cramps, confusion and seizures. These may be symptoms of SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion).
  • •Confusion
  • •Eosinophilic pneumonia (a rare type of lung inflammation)
  • •Runny or stuffy nose
  • •Severe kidney problems
  • •Changes in blood cell counts, such as decreased white and red blood cells, decreased hemoglobin, decreased platelets
  • •High calcium in the blood
  • •Abnormal liver function
  • •Abnormal heart electrical activity (ECG)
  • •Changes in lab values: high uric acid and high blood sugar levels
  • •Nearsightedness (myopia); blurred vision; reduced vision, decreased visual acuity or eye pain due to high eye pressure (possible signs of fluid buildup in the choroid or acute angle-closure glaucoma)
  • •Color change, numbness, and pain in fingers or toes (Raynaud's phenomenon)
  • •Worsening of systemic lupus erythematosus (a connective tissue disease)

Important Warnings

  • Do not take if you are allergic to perindopril, indapamide, other ACE inhibitors, sulfonamides, or any other ingredient in this medicine.
  • Do not take if you or a family member have had swelling of the face, tongue, or throat (angioedema) in the past, especially with other ACE inhibitor medicines.
  • Do not take if you have diabetes or kidney problems and are taking aliskiren for high blood pressure.
  • Do not take if you have severe liver disease or a brain disease caused by liver problems (hepatic encephalopathy).
  • Do not take if you are more than 3 months pregnant; it is also best to avoid this medicine during early pregnancy as it can harm your baby.
Show 1 more warnings
  • Do not take if you are currently taking or have recently taken sacubitril/valsartan (a medicine for heart failure) due to an increased risk of angioedema.

Use in Elderly Patients

Category C

Suitable for older adults, with specific precautions. Effectiveness is reduced in renal impairment. Consider risk of orthostatic hypotension and hyponatraemia and -kalemia. (updated 19.5.2025)